These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16436648)

  • 1. Topiramate in essential tremor: a double-blind, placebo-controlled trial.
    Ondo WG; Jankovic J; Connor GS; Pahwa R; Elble R; Stacy MA; Koller WC; Schwarzman L; Wu SC; Hulihan JF;
    Neurology; 2006 Mar; 66(5):672-7. PubMed ID: 16436648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials.
    Connor GS; Edwards K; Tarsy D
    Clin Neuropharmacol; 2008; 31(2):97-103. PubMed ID: 18382182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J;
    Headache; 2005; 45(10):1304-12. PubMed ID: 16324162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of topiramate on health-related quality of life indicators in chronic migraine.
    Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ
    Headache; 2007; 47(10):1398-408. PubMed ID: 18052949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects.
    Wilding J; Van Gaal L; Rissanen A; Vercruysse F; Fitchet M;
    Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1399-410. PubMed ID: 15486569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
    Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials.
    Thienel U; Neto W; Schwabe SK; Vijapurkar U;
    Acta Neurol Scand; 2004 Oct; 110(4):221-31. PubMed ID: 15355485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
    Diener HC; Agosti R; Allais G; Bergmans P; Bussone G; Davies B; Ertas M; Lanteri-Minet M; Reuter U; Sánchez Del Río M; Schoenen J; Schwalen S; van Oene J;
    Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
    Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor.
    Stacy MA; Elble RJ; Ondo WG; Wu SC; Hulihan J;
    Mov Disord; 2007 Apr; 22(6):833-8. PubMed ID: 17343274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type.
    Roy Chengappa K; Kupfer DJ; Parepally H; John V; Basu R; Buttenfield J; Schlicht P; Houck P; Brar JS; Gershon S
    Bipolar Disord; 2007 Sep; 9(6):609-17. PubMed ID: 17845276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of migraine on daily activities: effect of topiramate compared with placebo.
    Silberstein SD; Loder E; Forde G; Papadopoulos G; Fairclough D; Greenberg S
    Curr Med Res Opin; 2006 Jun; 22(6):1021-9. PubMed ID: 16846536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials.
    Kushner SF; Khan A; Lane R; Olson WH
    Bipolar Disord; 2006 Feb; 8(1):15-27. PubMed ID: 16411977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Topiramate for Essential Tremor: A Meta-Analysis of Randomized Controlled Trials.
    Chang KH; Wang SH; Chi CC
    Medicine (Baltimore); 2015 Oct; 94(43):e1809. PubMed ID: 26512577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zonisamide for essential tremor: an evaluator-blinded study.
    Handforth A; Martin FC; Kang GA; Vanek Z
    Mov Disord; 2009 Feb; 24(3):437-40. PubMed ID: 19117357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled, crossover trial of topiramate in essential tremor.
    Frima N; Grünewald RA
    Clin Neuropharmacol; 2006; 29(2):94-6. PubMed ID: 16614542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.
    Zesiewicz TA; Ward CL; Hauser RA; Sanchez-Ramos J; Staffetti JF; Sullivan KL
    Mov Disord; 2007 Jan; 22(2):279-82. PubMed ID: 17149715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.